Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating activities
Net income	$ 15,250	$ 3,566
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,655	1,511
Operating lease right-of-use assets expense	2,265	1,847
Foreign currency remeasurement (gain) loss	(1,448)	540
Stock-based compensation	7,270	9,620
Deferred income taxes	(115)	(95)
Other	253	1,064
Change in value of warrant liabilities	0	(474)
Changes in operating assets and liabilities:
Accounts receivable	23,245	9,198
Prepaid expenses and other current assets	1,806	1,895
Deferred contract costs and other assets	(4,524)	(2,637)
Accounts payable, accrued expenses and other current liabilities, and other liabilities	(23,195)	(27,895)
Operating lease liabilities	(2,596)	(1,856)
Deferred revenue	4,394	4,211
Net cash provided by operating activities	24,260	495
Investing activities
Maturities of investments	145	0
Purchases of investments	(40)	0
Capitalization of internal-use software	(432)	(452)
Purchase of property and equipment	(1,277)	(1,514)
Cash paid in business combinations, net of cash acquired	0	(14,893)
Net cash used in investing activities	(1,604)	(16,859)
Financing activities
Purchase of common stock	(59,809)	(11,905)
Proceeds from warrant exercises	0	87,344
Proceeds from stock option exercises	942	744
Other financing activities	(2)	(2)
Net cash (used in) provided by financing activities	(58,869)	76,181
Effect of exchange rates on cash	(712)	929
Net (decrease) increase in cash and cash equivalents	(36,925)	60,746
Cash and cash equivalents at beginning of period	481,060	290,735
Cash and cash equivalents at end of period	444,135	351,481
Supplemental disclosures of cash flow information
Income taxes paid	2,792	901
Unpaid purchase consideration transferred in connection with the business combination	0	5,499
Unpaid purchase of common stock	$ 943	$ 0